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Azoospermia is a descriptive term referring to ejaculates that lack spermatozoa without implying a specific
underlying cause. The traditional definition of azoospermia is ambiguous, which has ramifications on the
diagnostic criteria. This issue is further compounded by the apparent overlap between the definitions of
oligospermia and azoospermia. The reliable diagnosis of the absence of spermatozoa in a semen sample is an
important criterion not only for diagnosing male infertility but also for ascertaining the success of a vasectomy
and for determining the efficacy of hormonal contraception. There appears to be different levels of rigor in
diagnosing azoospermia in different clinical situations, which highlights the conflict between scientific research
and clinical practice in defining azoospermia.
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Azoospermia is a descriptive term referring to ejaculates
that lack spermatozoa without implying a specific under-
lying cause. The condition is almost always an unforeseen
finding when semen analysis is performed for any indica-
tion. Only in a few cases is azoospermia expected prior to
semen analysis, such as in cystic fibrosis, Klinefelter’s
syndrome and previous vasectomy cases. Such azoospermic
semen samples are found in up to 2% of the adult male
population and 5-59% of infertile men (1). It is important for
azoospermia to be distinguished from aspermia; specifi-
cally, the latter indicates the lack of semen formation or the
lack of ejaculation, such as in the case of total retrograde
ejaculation.
& THE DEFINITION AND DIAGNOSIS OF
AZOOSPERMIA
The appropriateness of the term azoospermia and the
reliability of diagnosing the absence of spermatozoa have
been the focus of debate over the past decade. The
traditional definition of azoospermia is ambiguous, which
has ramifications on the diagnostic criteria. The 5th edition
of the World Health Organization (WHO) manual (2010) (2)
adopted the following definition that was first proposed by
Eliason in 1981: ‘‘no spermatozoa are found in the sediment
of a centrifuged sample’’ (3). The American Urological
Association offers the following, more detailed definition:
‘‘no sperm after centrifugation at 3000 x g for 15 minutes
and examination of the pellet’’ (4). The aim of the
examination of the pelleted semen is to exclude cryptos-
permia, which is the presence of a very small number of live
sperm in a centrifuged pellet but not in a standard semen
analysis. Thus, the accurate assessment of very low sperm
counts is particularly important to avoid labeling severely
oligospermic men as azoospermic. In one study, centrifu-
ging semen at the low speed of 200 x g for 10 minutes
revealed that 18.6% of men diagnosed with ‘obstructive
azoospermia’ and 22.8% of men diagnosed with ‘non-
obstructive azoospermia’ had motile and non-motile sper-
matozoa in the semen pellet (5). In addition to these
laboratory considerations, the need for a change in the
clinical definition of azoospermia to include its etiology,
treatment, and prognosis has been repeatedly expressed
(6,7).
& THE ROUTINE ASSESSMENT OF SPERM COUNT
The total number of sperm in an ejaculate is influenced by
testicular sperm production, the integrity of the conducting
system, the presence of retrograde ejaculation (partial or
total), and the duration of abstinence before the analysis.
The WHO laboratory manual for the examination and
processing of human semen includes standards to enhance
the accuracy and precision of the sperm number estimates
to make them reproducible. Special attention is required to
control patient-related factors, such as the optimal absti-
nence duration of 2-7 days and the complete collection of
ejaculate. Frequent ejaculation within a short period of time
may deplete the epididymal stores, resulting in hardly any
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detectable sperm in the semen sample. Similarly, losing the
first portion of the ejaculate, which is the sperm-rich
portion, will significantly affect the accuracy of the assess-
ment of sperm number. The last portion of the ejaculate is
comprised mainly of seminal vesicular fluid (8). Thus,
patients need to receive clear instructions, both verbal and
written, on how to collect the entire ejaculate and to report
the loss of any fraction of the sample.
Sound laboratory techniques are needed to reduce the
amount of analytical error and enhance the precision of the
sperm count. These techniques include the adequate mixing
of the ejaculate, appropriate semen dilution if needed, and
comparison of the replicate counts to determine if they are
acceptably close (2). In addition to these technical details,
there is a high biological variation in semen quality,
including transient azoospermia, that may influence the
clinical interpretation of seminal parameters (9). Transient
azoospermia is also encountered secondary to toxic,
environmental, infectious or iatrogenic conditions. Given
this observation, repeating the examination of ejaculates on
two to three occasions is helpful to obtain baseline data
(9,10,11).
& THE MACROSCOPIC FEATURES OF
AZOOSPERMIC SEMEN SAMPLES
Opacity of the ejaculate
A normal liquefied semen sample with a normal cellular
content will have a homogenous grey-opalescent appear-
ance. Azoospermic samples and those with very low sperm
counts appear less opaque.
Semen volume
The seminal vesicles contribute up to 70% of the normal
ejaculate volume. The lower reference limit for semen
volume is 1.5 ml (5th percentile, 95% confidence interval
1.4–1.7) (2). Although a low sperm volume is more likely to
be due to the incomplete collection of the ejaculate, it may
also be due to obstruction of the ejaculatory duct or
congenital bilateral absence of the vas deferens (CBAVD)
(12,13). In a study of 105 males diagnosed with CBAVD, the
mean ejaculate volume was 0.7 ml (14). In CBAVD, there is
dysplasia or absence of the seminal vesicles with the loss of
its contribution to the semen volume. Retrograde ejaculation
and frequent orgasms may lead to what is described in lay
terms as ‘dry ejaculation’. In these situations, there will be
hardly any seminal fluid containing sperm.
Retrograde ejaculation should be suspected in any case of
azoospermia and when the seminal fluid volume is ,1 ml.
The diagnosis is confirmed by finding spermatozoa in the
post-ejaculatory urine. Spermatozoa found in the pellet after
urinary centrifugation will mostly be dead due to the
combined effects of osmotic stress, low pH and urea toxicity
(15). The recovery of high-quality sperm after the induced
modification of the urine composition and pH to facilitate its
use in the intracytoplasmic sperm injection technique (ICSI)
has been described (16,17).
Semen pH
The balance between the alkaline secretion of the seminal
vesicles and the acidic prostatic secretion determines the
semen pH. The importance of assessing the semen pH and
its physiological reference range has been a matter of
intense debate (18). The consensus lower reference value of
the pH of liquefied semen is 7.2 (2). In CBAVD, the semen
pH is characteristically low (,6.8) as a consequence of
dysplasia or the absence of the seminal vesicles. When the
fructose-rich alkaline secretion of the seminal vesicles is lost,
the seminal plasma is formed mainly from the relative
scanty and acidic prostatic secretion.
& THE DIAGNOSTIC VALUE OF MACROSCOPIC
FEATURES OF SEMEN IN AZOOSPERMIA
Semen volume and pH are important for determining the
differential diagnosis of the cause of azoospermia. In
patients with low-volume, acidic, azoospermic samples,
the differential diagnosis is CBAVD or bilateral complete
ejaculatory duct obstruction (EDO). A fructose assay is not
needed because the volume coupled with the pH indicates
no contribution from the seminal vesicles. Azoospermic
ejaculates with a normal volume and alkaline pH indicate
functional seminal vesicles and patent ejaculatory ducts.
The differential diagnosis includes spermatogenic failure or
an obstruction at the level of the more proximal vas deferens
or epididymis but does not include CBAVD or bilateral
EDO. In azoospermic cases with an alkaline, low-volume
ejaculate, the seminal vesicles are present and functional,
and at least one ejaculatory duct is open. Therefore, in cases
of azoospermia, attention to the details of semen volume
and pH may be quite helpful in establishing the diagnosis.
& MICROSCOPIC EXAMINATION OF CENTRIFUGED
SAMPLES TO DETECT SPERMATOZOA
When no spermatozoa are observed in replicate wet
preparations, the semen sample can be centrifuged, and the
pelleted semen can then be examined to determine if any
spermatozoa are present. Whether spermatozoa are found
in the pellet depends on the centrifugation time and speed
and on how much of the pellet is examined (5,19).
Centrifugation time and speed
In the literature, there are different recommendations for
the speed and time of centrifugation (Table 1). These
recommendations appear not only inconsistent but also
indecisive when terms such as ‘at least’ and ‘less than’ are
used. In one study that attempted to resolve this confusion,
25 ejaculates from ‘azoospermic men’ were centrifuged at
600 x g for 10 minutes, and no sperm were found in the
pellets (20). However, when supernatants resulting from the
600 x g centrifugation of the samples were centrifuged at
1000 x g for 15 minutes, spermatozoa were detected.
Because no more sperm-containing pellets were detected
by centrifuging the 1000 x g supernatant at 3000 x g for 15
minutes, the authors concluded that a minimum of 1000 x g
for 15 minutes was adequate for the detection of azoosper-
mia. The same study (20) demonstrated that centrifugation
at 3000 x g for 15 minutes did not remove spermatozoa from
the supernatant of 23 of 25 normozoospermic samples.
Another study examined the interplay between the centri-
fugation speed and duration and demonstrated a dramatic
increase in the appearance of spermatozoa in the pellet with
both increasing time (10-15 minutes) and speed (600-3600 x
g) of centrifugation (21). Thus, the accuracy of any
centrifugation protocol of less than 3000 x g in pelleting all
the spermatozoa in an ejaculate is uncertain. However, after
high-speed centrifugation (3000 x g), motility may be lost
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(23), and the concentration will therefore be underestimated
(22). This literature survey indicates that the replication of
results among laboratories using different centrifugal forces
is unlikely to be consistent (22).
The most recent WHO manual (2010) suggested that
when assessing an apparently azoospermic sample, con-
sideration must be given to whether subjective data on the
presence and motility of spermatozoa are sufficient or
whether accurate spermatozoa counts are required. For
example, when motile spermatozoa are sought in a post-
vasectomy semen sample, the high-speed centrifugation of
spermatozoa must be avoided, and only an aliquot of the
undiluted sample can be assessed. The microscopic exam-
ination in this procedure can take longer (up to 10 minutes)
than low-speed centrifugation because the sample will have
a high cellular background. When no spermatozoa are
observed in replicate assessments of pelleted semen, the
WHO manual (2010) recommends reporting the sample as
‘‘No spermatozoa were seen in the replicates, too few for
accurate determination of concentration’’. This guarded
reporting takes into account the errors of counting (2,22)
and the possibility that the absence of spermatozoa from the
examined aliquot does not necessarily indicate their absence
from the remainder of the sample. This approach is adopted
when a case of apparent azoospermia is examined further to
determine if there are enough spermatozoa to fertilize a
limited number of eggs using the ICSI technique.
However, when the aim of pelleting semen samples is to
obtain an accurate assessment of the sperm number, high-
speed centrifugation should be used (3000 x g). This
approach is necessary for male hormone contraception
research and for diagnostic purposes, such as in CBAVD
and the confirmation of sperm clearance after a vasectomy.
In these situations, rendering spermatozoa immotile and
promoting reactive oxygen species-induced sperm damage
as a result of the high-speed centrifugation are irrelevant.
Alternatives to centrifugation
One alternative to centrifugation is the use of a low semen
dilution (1+1 [1:2]) to evaluate larger volumes by either
preparing more chambers or using chambers with an
inherently larger volume, such as the improved Neubauer
chamber (2,22). Because this technique utilizes a fixative to
immobilize the sperm cells, it is not suitable when the
semen sample is examined for the potential harvesting of
sperm, if found, for ICSI treatment. The absence of
spermatozoa from the examined aliquot does not necessa-
rily indicate their absence from the remainder of the sample.
If no spermatozoa are found in replicate assessments, the
WHO manual (2010) recommends that the sample be
reported as ‘‘No spermatozoa were seen in the replicates,
too few for accurate determination of concentration’’ (2).
Another alternative is the use of fluorescence microscopy
using an aliquot of semen diluted 1:2 with a fixative
containing Hoechst 33342 bisbenzimide fluorochrome
(1 mg/l) to label the sperm nuclei (2,22). Again, this method
is not suitable when the identified sperm are used for ICSI
treatment.
& FUTURE DEVELOPMENTS
The standard method of semen analysis is to assess the
macroscopic appearance and cellular content of the ejacu-
late. Investigation of the molecular composition of seminal
plasma to explain the cause of sperm and seminal plasma
abnormalities has thus far been limited to the evaluation of
the fructose content and, in later years, the level of reactive
oxygen species in the plasma (26,27,28)). More recently, the
study of the seminal plasma proteome appears to offer the
potential to identify biomarkers that may aid in the
diagnosis of the causes of azoospermia. Many of the
proteins in the seminal plasma are expressed in the testis
and epididymis and are linked to fertility. Some of these
proteins may be useful as noninvasive biomarkers to
discriminate non-obstructive azoospermia from obstructive
azoospermia (29).
The reliable diagnosis of the absence of spermatozoa in a
semen sample is important for diagnosing male infertility,
ascertaining the success of vasectomy, and determining the
efficacy of hormonal contraception. From the laboratory
point of view, inconsistent approaches to studying semen
and imprecision can handicap both research and clinical
practice (30). These technical issues are further compounded
by the apparent overlap between the definitions of
oligospermia and azoospermia. This overlap is present in
the WHO manual (2010), and although appearing unjusti-
fied, it echoes the different levels of rigor in diagnosing
azoospermia in different clinical situations and highlights
the conflict between scientific research and clinical practice
in defining azoospermia.
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